Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bader

Showing results (21-30 of 609) with videos related to

Pageof 61
Sort By:
Neuroendocrinology|December 6, 2003
Brain renin-angiotensin system. Lessons from functional genomicsOvidiu Baltatu, Michael Bader
Toxicology Letters|November 11, 2005
Follow-up biomonitoring after accidental exposure to acrylonitrile:- implications for protein adducts as a dose monitor for short-term exposuresMichael Bader, Renate Wrbitzky
American Journal of Hypertension|April 21, 2010
Bradykinin B2 receptor agonism: a novel therapeutic strategy for myocardial infarction?Johan Duchene, Michael Bader
Journal of Molecular Medicine (Berlin, Germany)|August 22, 2015
Receptors, G proteins, and integration of calcium signallingThomas Gudermann, Michael Bader
Pharmacological Reports : PR|November 12, 2009
Overview on 5-HT receptors and their role in physiology and pathology of the central nervous systemMałgorzata Filip, Michael Bader
Expert Opinion on Therapeutic Targets|November 24, 2017
Kinin B1 receptors as a therapeutic target for inflammationFatimunnisa Qadri, Michael Bader
Neurochemical Research|November 17, 2018
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal ModelsNatalia Alenina, Michael Bader
Medical Research Archives|November 28, 2022
Why Angiotensin II is a Poor Choice for Circulatory Support of Ventilated COVID-19 Patients Compared to VasopressinRobert C Speth, Michael Bader
Hypertension (Dallas, Tex. : 1979)|March 1, 2006
Matrix reloaded: the matrix metalloproteinase paradoxAnna N Panek, Michael Bader
Biochemical Pharmacology|September 15, 2023
The contribution of the AT1 receptor to erythropoiesisAndré F Rodrigues, Michael Bader
Pageof 61

Showing results (21-30 of 609) with videos related to

Sort By:
Pageof 61
Neuroendocrinology|December 6, 2003
Brain renin-angiotensin system. Lessons from functional genomicsOvidiu Baltatu, Michael Bader
Toxicology Letters|November 11, 2005
Follow-up biomonitoring after accidental exposure to acrylonitrile:- implications for protein adducts as a dose monitor for short-term exposuresMichael Bader, Renate Wrbitzky
American Journal of Hypertension|April 21, 2010
Bradykinin B2 receptor agonism: a novel therapeutic strategy for myocardial infarction?Johan Duchene, Michael Bader
Journal of Molecular Medicine (Berlin, Germany)|August 22, 2015
Receptors, G proteins, and integration of calcium signallingThomas Gudermann, Michael Bader
Pharmacological Reports : PR|November 12, 2009
Overview on 5-HT receptors and their role in physiology and pathology of the central nervous systemMałgorzata Filip, Michael Bader
Expert Opinion on Therapeutic Targets|November 24, 2017
Kinin B1 receptors as a therapeutic target for inflammationFatimunnisa Qadri, Michael Bader
Neurochemical Research|November 17, 2018
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal ModelsNatalia Alenina, Michael Bader
Medical Research Archives|November 28, 2022
Why Angiotensin II is a Poor Choice for Circulatory Support of Ventilated COVID-19 Patients Compared to VasopressinRobert C Speth, Michael Bader
Hypertension (Dallas, Tex. : 1979)|March 1, 2006
Matrix reloaded: the matrix metalloproteinase paradoxAnna N Panek, Michael Bader
Biochemical Pharmacology|September 15, 2023
The contribution of the AT1 receptor to erythropoiesisAndré F Rodrigues, Michael Bader
Pageof 61